1. Home
  2. OCGN vs FRGE Comparison

OCGN vs FRGE Comparison

Compare OCGN & FRGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCGN
  • FRGE
  • Stock Information
  • Founded
  • OCGN 2013
  • FRGE 2014
  • Country
  • OCGN United States
  • FRGE United States
  • Employees
  • OCGN N/A
  • FRGE N/A
  • Industry
  • OCGN Biotechnology: Biological Products (No Diagnostic Substances)
  • FRGE Computer Software: Prepackaged Software
  • Sector
  • OCGN Health Care
  • FRGE Technology
  • Exchange
  • OCGN Nasdaq
  • FRGE Nasdaq
  • Market Cap
  • OCGN 321.7M
  • FRGE 262.8M
  • IPO Year
  • OCGN N/A
  • FRGE N/A
  • Fundamental
  • Price
  • OCGN $1.52
  • FRGE $20.60
  • Analyst Decision
  • OCGN Strong Buy
  • FRGE Buy
  • Analyst Count
  • OCGN 2
  • FRGE 5
  • Target Price
  • OCGN $7.00
  • FRGE $35.50
  • AVG Volume (30 Days)
  • OCGN 5.9M
  • FRGE 99.6K
  • Earning Date
  • OCGN 11-05-2025
  • FRGE 11-04-2025
  • Dividend Yield
  • OCGN N/A
  • FRGE N/A
  • EPS Growth
  • OCGN N/A
  • FRGE N/A
  • EPS
  • OCGN N/A
  • FRGE N/A
  • Revenue
  • OCGN $4,754,000.00
  • FRGE $90,840,000.00
  • Revenue This Year
  • OCGN N/A
  • FRGE $32.73
  • Revenue Next Year
  • OCGN N/A
  • FRGE $21.74
  • P/E Ratio
  • OCGN N/A
  • FRGE N/A
  • Revenue Growth
  • OCGN N/A
  • FRGE 14.78
  • 52 Week Low
  • OCGN $0.52
  • FRGE $6.60
  • 52 Week High
  • OCGN $1.90
  • FRGE $24.90
  • Technical
  • Relative Strength Index (RSI)
  • OCGN 48.14
  • FRGE 67.95
  • Support Level
  • OCGN $1.47
  • FRGE $16.16
  • Resistance Level
  • OCGN $1.65
  • FRGE $22.20
  • Average True Range (ATR)
  • OCGN 0.11
  • FRGE 1.17
  • MACD
  • OCGN -0.03
  • FRGE 0.47
  • Stochastic Oscillator
  • OCGN 13.51
  • FRGE 75.26

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

About FRGE Forge Global Holdings Inc.

Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.

Share on Social Networks: